(Q37766175)

22 August 2017

1 reference

title

Sudden death in hypertrophic cardiomyopathy. (English)

1 reference

22 August 2017

Barry J Maron

1

1 reference

PubMed ID

20559995

22 August 2017

language of work or name

English

0 references

publication date

13 November 2009

1 reference

Journal of Cardiovascular Translational Research

22 August 2017

1 reference

22 August 2017

2

1 reference

22 August 2017

4

1 reference

22 August 2017

368-380

1 reference

https://scigraph.springernature.com/pub.10.1007/s12265-009-9147-0

22 August 2017

0 references

cites work

Hypertrophic cardiomyopathy. Clinical spectrum and treatment.

1 reference

https://api.crossref.org/works/10.1007%2FS12265-009-9147-0

Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-009-9147-0

Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-009-9147-0

Sudden cardiac arrest in hypertrophic cardiomyopathy in the absence of conventional criteria for high risk status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-009-9147-0

Epidemiology of Hypertrophic Cardiomyopathy–Related Death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-009-9147-0

Syncope and risk of sudden death in hypertrophic cardiomyopathy.

21 January 2018

1 reference

12 December 2020

Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy

1 reference

12 December 2020

Quantitative analysis of the distribution of cardiac muscle cell disorganization in the left ventricular wall of patients with hypertrophic cardiomyopathy

1 reference

12 December 2020

Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy

1 reference

12 December 2020

Clinical course of hypertrophic cardiomyopathy with survival to advanced age.

1 reference

12 December 2020

Asymmetrical hypertrophy of the heart in young adults

1 reference

12 December 2020

Ventricular tachycardia complicating alcohol septal ablation

1 reference

12 December 2020

Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings

1 reference

12 December 2020

1 reference

12 December 2020

Implications of arrhythmias and prevention of sudden death in hypertrophic cardiomyopathy.

1 reference

12 December 2020

Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy

1 reference

12 December 2020

Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006.

1 reference

12 December 2020

Role of percutaneous septal ablation in hypertrophic obstructive cardiomyopathy

1 reference

12 December 2020

Occurrence of de novo sustained monomorphic ventricular tachycardia induced after percutaneous transluminal alcohol septal myocardial ablation for hypertrophic obstructive cardiomyopathy

1 reference

12 December 2020

Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study

1 reference

12 December 2020

Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy

1 reference

12 December 2020

Effects of a meal on hemodynamic function at rest and during exercise in patients with hypertrophic cardiomyopathy

1 reference

12 December 2020

The utilization of the implantable defibrillator--a European enigma

1 reference

12 December 2020

Myocardial bridging, a frequent component of the hypertrophic cardiomyopathy phenotype, lacks systematic association with sudden cardiac death

1 reference

12 December 2020

Relation of electrocardiographic patterns to phenotypic expression and clinical outcome in hypertrophic cardiomyopathy

1 reference

12 December 2020

Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.

1 reference

12 December 2020

Determinants of implantable defibrillator discharges in high-risk patients with hypertrophic cardiomyopathy

1 reference

12 December 2020

Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy

1 reference

12 December 2020

Hypertrophic cardiomyopathy: an important global disease

1 reference

12 December 2020

Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographic analysis of 8080 adults

1 reference

12 December 2020

Cardioverter-defibrillator implantation in high-risk patients with hypertrophic cardiomyopathy

1 reference

12 December 2020

Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy.

1 reference

12 December 2020

Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients

1 reference

12 December 2020

Iatrogenic deaths following treatment for hypertrophic obstructive cardiomyopathy: case reports and an approach to the autopsy and death certification

1 reference

12 December 2020

Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy

1 reference

12 December 2020

Circadian patterns in the occurrence of malignant ventricular tachyarrhythmias triggering defibrillator interventions in patients with hypertrophic cardiomyopathy

1 reference

12 December 2020

Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy

1 reference

12 December 2020

Impact of Atrial Fibrillation on the Clinical Course of Hypertrophic Cardiomyopathy

1 reference

12 December 2020

Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy

1 reference

12 December 2020

IDIOPATHIC HYPERTROPHIC SUBAORTIC STENOSIS. I. A DESCRIPTION OF THE DISEASE BASED UPON AN ANALYSIS OF 64 PATIENTS

1 reference

12 December 2020

Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy

1 reference

12 December 2020

Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies

1 reference

12 December 2020

Evidence that pharmacological strategies lack efficacy for the prevention of sudden death in hypertrophic cardiomyopathy

1 reference

12 December 2020

Functional obstruction of the left ventricle; acquired aortic subvalvar stenosis

1 reference

12 December 2020

Myocardial infarction after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: evaluation by contrast-enhanced magnetic resonance imaging

1 reference

12 December 2020

Prevalence of hypertrophic cardiomyopathy in an outpatient population referred for echocardiographic study

1 reference

12 December 2020

Occurrence and Frequency of Arrhythmias in Hypertrophic Cardiomyopathy in Relation to Delayed Enhancement on Cardiovascular Magnetic Resonance

1 reference

12 December 2020

American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the Euro

1 reference

12 December 2020

Hypertrophic cardiomyopathy, sudden death, and implantable cardiac defibrillators: how low the bar?

1 reference

12 December 2020

Effect of Left Ventricular Outflow Tract Obstruction on Clinical Outcome in Hypertrophic Cardiomyopathy

1 reference

12 December 2020

Hypertrophic cardiomyopathy: management, risk stratification, and prevention of sudden death

1 reference

12 December 2020

Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction

1 reference

12 December 2020

Hypertrophic cardiomyopathy: a systematic review

1 reference

12 December 2020

Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics

1 reference

12 December 2020

Circadian rhythm of appropriate implantable cardioverter defibrillator discharges in patients with hypertrophic cardiomyopathy

1 reference

12 December 2020

Morphology of necrosis and repair after transcoronary ethanol ablation of septal hypertrophy

1 reference

12 December 2020

The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms

1 reference

12 December 2020

Cost-effectiveness of implanted defibrillators in young people with inherited cardiac arrhythmias.

1 reference

12 December 2020

Percutaneous versus surgical treatment for patients with hypertrophic obstructive cardiomyopathy and enlarged anterior mitral valve leaflets

1 reference

12 December 2020

Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin T genes in hypertrophic cardiomyopathy: a comprehensive outpatient perspective.

1 reference

12 December 2020

Relation of extreme left ventricular hypertrophy to age in hypertrophic cardiomyopathy

1 reference

12 December 2020

Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy.

1 reference

12 December 2020

The management of hypertrophic cardiomyopathy

1 reference

12 December 2020

Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group

1 reference

12 December 2020

Risks and challenges of implantable cardioverter-defibrillators in young adults

1 reference

12 December 2020

Long-term follow-up of implantable cardioverter defibrillator therapy for hypertrophic cardiomyopathy.

1 reference

12 December 2020

Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance

1 reference

12 December 2020

Predictors of sudden cardiac death in hypertrophic cardiomyopathy

1 reference

12 December 2020

Sudden death in hypertrophic cardiomyopathy: identification of high risk patients.

1 reference

12 December 2020

Prevalence and severity of "benign" mutations in the beta-myosin heavy chain, cardiac troponin T, and alpha-tropomyosin genes in hypertrophic cardiomyopathy

1 reference

12 December 2020

Controversies in cardiovascular medicine. Surgical myectomy remains the primary treatment option for severely symptomatic patients with obstructive hypertrophic cardiomyopathy

1 reference

12 December 2020

Efficacy of Implantable Cardioverter–Defibrillators for the Prevention of Sudden Death in Patients with Hypertrophic Cardiomyopathy

1 reference

12 December 2020

Significance of appropriate defibrillator shock 3 hours and 20 minutes following implantation in a patient with hypertrophic cardiomyopathy

1 reference

12 December 2020

Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy

1 reference

12 December 2020

Paced ventricular electrogram fractionation predicts sudden cardiac death in hypertrophic cardiomyopathy

1 reference

12 December 2020

Diagnostic, prognostic, and therapeutic implications of genetic testing for hypertrophic cardiomyopathy

1 reference

12 December 2020

Sudden death in young athletes

1 reference

12 December 2020

Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients

1 reference

12 December 2020

Multiple mutations in genetic cardiovascular disease: a marker of disease severity?

1 reference

12 December 2020

Clinical course of hypertrophic cardiomyopathy in a regional United States cohort

1 reference

12 December 2020

Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy

1 reference

12 December 2020

The case for myocardial ischemia in hypertrophic cardiomyopathy

1 reference

12 December 2020

Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy.

1 reference

12 December 2020

Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy

1 reference

12 December 2020

Life expectancy gains and cost-effectiveness of implantable cardioverter/defibrillators for the primary prevention of sudden cardiac death in patients with hypertrophic cardiomyopathy

1 reference

12 December 2020

Sustained ventricular tachycardia following alcohol septal ablation for hypertrophic obstructive cardiomyopathy

1 reference

12 December 2020

Prognostic value of systemic blood pressure response during exercise in a community-based patient population with hypertrophic cardiomyopathy

1 reference

12 December 2020

Role of alcohol septal ablation in treatment of obstructive hypertrophic cardiomyopathy

1 reference

12 December 2020

Outcome of patients with hypertrophic cardiomyopathy and a normal electrocardiogram

1 reference

12 December 2020

Implantable defibrillators and prevention of sudden death in hypertrophic cardiomyopathy

1 reference

12 December 2020

Lessons from the failure and recall of an implantable cardioverter-defibrillator.

1 reference

12 December 2020

Adverse prognosis of patients with hypertrophic cardiomyopathy who have epicardial coronary artery disease

1 reference

12 December 2020

Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy

1 reference

12 December 2020

Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy

1 reference

12 December 2020

The Genetic Basis for Cardiomyopathy

1 reference

12 December 2020

10.1007/S12265-009-9147-0

Identifiers

DOI

1 reference

22 August 2017

1 reference

PubMed ID

20559995